Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

The effects of linking substituents on the in vivo behavior of site-directed, peptide-based, diagnostic radiopharmaceuticals.

The effects of linking substituents on the in vivo behavior of site-directed, peptide-based, diagnostic radiopharmaceuticals. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • The effects of linking substituents on the in vivo behavior of site-directed, peptide-based, diagnostic radiopharmaceuticals. Abstract Text:

    adam f prasanphanichAdam F Prasanphanich,stephanie r laneStephanie R Lane,said d figueroaSaid D Figueroa,lixin maLixin Ma,tammy l roldTammy L Rold,gary l sieckmanGary L Sieckman,timothy j hoffmanTimothy J Hoffman,joseph m mccrateJoseph M McCrate,charles j smithCharles J Smith,

    A number of human cancers are known to over-express the gastrin-releasing peptide receptor (GRPr) on cell surfaces. The high specificity and affinity of bombesin (BBN), an amphibian analogue of mammalian gastrin-releasing peptide, for the GRPr makes it an ideal candidate for delivery of diagnostic probes, such as 99mTc radiometal, to tumor sites. An optimized targeting agent possesses high tumor uptake with minimal uptake in normal tissues. In this study, 99mTc-targeting vectors of bombesin using various amino acid/aliphatic pharmacokinetic modifiers or linking groups were evaluated to determine the effect of the spacer on receptor binding affinity, internalization/externalization and biodistribution. Conjugates of the general type [DPR-X-BBN] (X = amino acid/aliphatic pharmacokinetic modifier) were synthesized by solid phase peptide synthesis (SPPS) and metallated with either low-valent, radioactive Tc-99m(I) or non-radioactive Re(I)-tricarbonyl precursors. All of the new non-metallated and metallated conjugates were characterized by electrospray ionization mass spectrometry (ESI-MS). Receptor binding affinity, internalization/externalization and biodistribution studies in normal (CF-1) and tumor (human prostate PC-3-bearing mice) are reported. The effectiveness of targeting xenografted PC-3 tumors in rodents for two of the new 99mTc-BBN conjugates is demonstrated herein using small animal single photon emission computed tomography (SPECT).

    The effects of linking substituents on the in vivo behavior of site-directed, peptide-based, diagnostic radiopharmaceuticals. Publishing Authors By Initials

    af prasanphanichAF Prasanphanich,sr laneSR Lane,sd figueroaSD Figueroa,l maL Ma,tl roldTL Rold,gl sieckmanGL Sieckman,tj hoffmanTJ Hoffman,jm mccrateJM McCrate,cj smithCJ Smith,

    For similar surgical procedures, operative: transplantation: transplantation, heterologous research abstracts see: surgical procedures, operative: transplantation: transplantation, heterologous research

    PUBMED ID PMID:

    MEDLINE DATE:

    The effects of linking substituents on the in vivo behavior of site-directed, peptide-based, diagnostic radiopharmaceuticals. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: In vivo (Athens, Greece)

    VOLUME: 21

    Page Numbers: 1-16

    Journal Abbreviation: In Vivo

    ISSN: 0258-851X

    DAY: 3

    MONTH: 12

    YEAR: 2007

    The effects of linking substituents on the in vivo behavior of site-directed, peptide-based, diagnostic radiopharmaceuticals. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8806809

    The effects of linking substituents on the in vivo behavior of site-directed, peptide-based, diagnostic radiopharmaceuticals. Keywords Mesh Terms:

    KEYWORDS: Transplantation, Heterologous

    MESH TERMS: metabolism

    Chemical & Substance for Abstract: The effects of linking substituents on the in vivo behavior of site-directed, peptide-based, diagnostic radiopharmaceuticals. Information

    Substance Name: Technetium

    Registry Number: 7440-26-8

    Grant and Affiliation Information for The effects of linking substituents on the in vivo behavior of site-directed, peptide-based, diagnostic radiopharmaceuticals.

    AFFILIATION: Department of Radiology, University of Missouri-Columbia School of Medicine, Columbia, Missouri, 65211, USA.

    Country: Greece

    Greece Research PublicationGreece Research Publication

    AGENCY: United States NIBIB

    GRANT: 1R21EB000833-01

    ACRONYM: EB

    MEDLINETA: In Vivo

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    The effects of linking substituents on the in vivo behavior of site-directed, peptide-based, diagnostic radiopharmaceuticals Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News